CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dilger, J. A.
Right arrow Articles by Tetzlaff, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dilger, J. A.
Right arrow Articles by Tetzlaff, J.
Canadian Journal of Anesthesia 51:20-24 (2004)
© Canadian Anesthesiologists' Society, 2004

General Anesthesia

Remifentanil provides better analgesia than alfentanil during breast biopsy surgery under monitored anesthesia care

[Le rémifentanil fournit une meilleure analgésie que l’alfentanil pendant la biopsie mammaire réalisée sous surveillance anesthésique]

John A. Dilger, MD*, Juraj Sprung, MD PhD*, Walter Maurer, MD{dagger} and John Tetzlaff, MD{dagger}

* From the Departments of Anesthesiology, Mayo Clinic, Rochester, Minnesota,
{dagger} and The Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Address correspondence to: Dr. John A. Dilger, Department of Anesthesiology, Mayo Clinic, 200 First Street, S.W., Rochester, Minnesota 55905, USA. Phone: 507-284-9700; Fax: 507-284-0120; E-mail: dilger.john{at}mayo.edu

Purpose: To compare the analgesic effects of remifentanil and alfentanil during breast biopsy under monitored anesthesia care (MAC).

Methods: Sixty patients received sedation with propofol (50 µg•kg-1•min-1). After receiving a loading dose of opioid (either remifentanil 0.5 µg•kg-1, or alfentanil 2.5 µg•kg-1), an infusion was initiated (remifentanil 0.05 µg•kg-1•min-1 or alfentanil 0.25 µg•kg-1•min-1), and this was supplemented with local anesthetic infiltration. The pain was evaluated with a ten-point visual analogue scale (VAS) during local anesthetic infiltration and deep tissue dissection. Inadequate analgesia, defined as VAS scores >= 5, was treated first with boluses of opioid (remifentanil group 10 µg or alfentanil group 50 µg) and if inadequate after two treatments with additional local anesthetic. Postoperative times were recorded including the times until discharge criteria were achieved and patient’s actual discharge.

Results: The pain scores were similar between the two groups during the initial injections of local anesthetic in the breast, however, patients in the remifentanil group had lower mean pain scores during deep tissue dissection (2.3 vs 4.3, P < 0.01). Patients in the remifentanil group required fewer rescue doses of opioid (1.9 vs 3.6, P < 0.03) and local anesthetic (5 vs 15, P < 0.006). The two study groups had comparable speed of recovery.

Conclusion: Remifentanil was a better opioid choice than alfentanil for breast biopsy under MAC at the doses studied, but it did not increase the rapidity in which patients recovered postoperatively.




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
P. Lena, C. J. Mariottini, N. Balarac, J. J. Arnulf, A. Mihoubi, and R. Martin
Remifentanil versus propofol for radio frequency treatment of atrial flutter: [Remifentanil versus propofol pour le traitement des flutters auriculaires par radiofrequences].
Can J Anesth, April 1, 2006; 53(4): 357 - 362.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.